Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Taft

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Drug Discovery Technologies|February 14, 2006
The isolated perfused rat kidney model: a useful tool for drug discovery and developmentDavid R Taft
Life (Basel, Switzerland)|July 29, 2025
PBPK Modeling of Acetaminophen in Pediatric Populations: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic ExposureSonia Sharma, David R Taft
Journal of Pharmaceutical Sciences|March 21, 2008
Renal excretion of emtricitabine II. effect of trimethoprim on emtricitabine excretion: In vitro and in vivo studiesTomoko Nakatani-Freshwater, David R Taft
Journal of Pharmaceutical Sciences|March 21, 2008
Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretionTomoko Nakatani-Freshwater, David R Taft
AAPS Pharmscitech|July 2, 2016
Evaluating the Potential for Delivery of Irinotecan via the Buccal Route: Physicochemical Characterization and In Vitro Permeation Assessment Across Porcine Buccal MucosaVidhi Shah, Robert A Bellantone, David R Taft
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretionAntoinette D Ajavon, Peter L Bonate, David R Taft
Current Drug Discovery Technologies|February 16, 2019
Using PBPK Modeling to Predict Drug Exposure and Support Dosage Adjustments in Patients With Renal Impairment: An Example with LamivudineKushal Shah, Briann Fischetti, Agnes Cha, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 1, 2019
Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in RatsJennypher Mudunuru, Chen Ren, David R Taft, et al.
Biopharmaceutics & Drug Disposition|May 6, 2017
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populationsVamshi Krishna Jogiraju, Suvarchala Avvari, Rakesh Gollen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2006
Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidneyTomoko Nakatani-Freshwater, Mariana Babayeva, Aruna Dontabhaktuni, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Drug Discovery Technologies|February 14, 2006
The isolated perfused rat kidney model: a useful tool for drug discovery and developmentDavid R Taft
Life (Basel, Switzerland)|July 29, 2025
PBPK Modeling of Acetaminophen in Pediatric Populations: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic ExposureSonia Sharma, David R Taft
Journal of Pharmaceutical Sciences|March 21, 2008
Renal excretion of emtricitabine II. effect of trimethoprim on emtricitabine excretion: In vitro and in vivo studiesTomoko Nakatani-Freshwater, David R Taft
Journal of Pharmaceutical Sciences|March 21, 2008
Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretionTomoko Nakatani-Freshwater, David R Taft
AAPS Pharmscitech|July 2, 2016
Evaluating the Potential for Delivery of Irinotecan via the Buccal Route: Physicochemical Characterization and In Vitro Permeation Assessment Across Porcine Buccal MucosaVidhi Shah, Robert A Bellantone, David R Taft
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretionAntoinette D Ajavon, Peter L Bonate, David R Taft
Current Drug Discovery Technologies|February 16, 2019
Using PBPK Modeling to Predict Drug Exposure and Support Dosage Adjustments in Patients With Renal Impairment: An Example with LamivudineKushal Shah, Briann Fischetti, Agnes Cha, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 1, 2019
Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in RatsJennypher Mudunuru, Chen Ren, David R Taft, et al.
Biopharmaceutics & Drug Disposition|May 6, 2017
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populationsVamshi Krishna Jogiraju, Suvarchala Avvari, Rakesh Gollen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2006
Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidneyTomoko Nakatani-Freshwater, Mariana Babayeva, Aruna Dontabhaktuni, et al.
Pageof 3